Chargement en cours...
Aprepitant for the management of nausea with inpatient IV dihydroergotamine
OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant, a substance P/neurokinin A receptor antagonist, in controlling nausea associated with IV dihydroergotamine (DHE) administered for medically refractory migrainous headache in patients not responding to standard antiemetics or with...
Enregistré dans:
| Publié dans: | Neurology |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5067541/ https://ncbi.nlm.nih.gov/pubmed/27629088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003206 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|